It acts as a potent agonist of the IGF-1 receptor, activating signaling pathways such as PI3K/Akt and MAPK to promote: Cell Growth and Division : Enhances proliferation in diverse cell lineages, including ectodermal (e.g., oligodendrocytes, motor neurons) and mesodermal (e.g., osteocytes, chondrocytes, muscle cells) types, supporting stem cell research and large-scale biopharmaceutical manufacturing
7LLL: Deganutti G, Liang YL, Zhang X, Khoshouei M, Clydesdale L, Belousoff MJ, Venugopal H, Truong TT, Glukhova A, Keller AN, Gregory KJ, Leach K, Christopoulos A, Danev R, Reynolds CA, Zhao P, Sexton PM, Wootten D
There is no approved dosing regimen for retatrutide in the UK, as it remains an unlicensed investigational medicine not yet authorised by the MHRA or EMA
mTORC1 inhibition uncouples lipolysis and thermogenesis in white adipose tissue to contribute to alcoholic liver disease
YangLZhaoYWangYLiuLZhangXLiBet al